US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday that its board of directors has approved a dividend of USD1.73 per share on its outstanding common stock for the second quarter of 2026.
This amount is unchanged from the previous quarterly dividend.
The Q2 dividend is payable on 10 June 2026, to shareholders of record at the close of business on 15 May 2026.
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share
Convatec launches co-branded eakin freeseal ostomy seal in North America
UHS to acquire Talkspace for USD835m
Abbott announces quarterly dividend
Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit
Alvotech reports positive PK study results for AVT80 biosimilar candidate